Biogen (BIIB) Sees -6.4% Decline Over Four Weeks, Potential for Trend Reversal Ahead
Nov 4, 2024
Biogen Invest Information
Biogen Q3 Earnings Review: Why I Remain Optimistic Despite Difficult Quarter
Nov 1, 2024
Investigation on Behalf of BIIB Investors by Faruqi & Faruqi, LLP
Jul 21, 2024
Eisai Submits LEQEMBI® (lecanemab-irmb) Biologics License Update to FDA for Early Alzheimer's Treatment – Biogen Stocks in Focus
Jun 10, 2024
Biogen Showcases Fresh Insights on Alzheimer's Disease at AD/PD™ 2024 Conference
Mar 5, 2024
Biogen BIIB Downgraded by StockNews.com Amidst Various Analyst Reports
Nov 13, 2023
Sangamo Therapeutics (NASDAQ:SGMO) Receives New Coverage From StockNews.com Amid Financial Analysis From Significant Players
Nov 12, 2023